NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 263

Law Patients Access Oil 263

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

SpeedWeed

APRIL 9, 2021

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals. This law allows a limited number of patients to use CBD-based medicine with no more than 0.5 percent THC content.

Pharmaceutical 52

Pharmaceutical Chronic Pain Programs Patients 52

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. A 2019 study found that 76% of patients in the U.S. A 2019 study found that 76% of patients in the U.S.

Programs 52

Programs Chronic Pain Treatment Conditions 52

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. Recently, Virginia legalization has changed in several ways.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

MMJ Recs

FEBRUARY 3, 2024

In recent years, the landscape of medical marijuana laws has evolved, presenting new opportunities and challenges for patients, healthcare providers, and industry stakeholders. Understanding these regulations is crucial for patients, caregivers, and dispensaries alike to ensure compliance with the law.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Send a message to your lawmakers in support of medical marijuana access. AL resident? AZ resident?

Legislation 244

Legislation Patients Decriminalization Access 244

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JANUARY 18, 2022

Texas Original Compassionate Cultivation assembled a focus group of veterans suffering from PTSD to evaluate symptom response, product preference and effects on supplemental pharmaceutical consumption. The focus group consisted of veterans suffering from PTSD who qualify for medical cannabis under the expanded Compassionate Use Program.

Patients 52

Patients Tincture Pharmaceutical Cultivation 52

Cannabis Law Report

OCTOBER 28, 2021

. “This investment will see Greenlab’s researchers carrying out rigorous trials and lab testing at its leased facilities at Lincoln University to ensure a consistently high-quality and effective pharmaceutical product.”

Programs 52

Programs Research and Development Pharmaceutical Cultivation 52

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Poland’s medical cannabis program. Patients must have a doctor’s prescription as well as permission from a regional pharmaceutical inspector to obtain cannabis products.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

Cannabis Law Report

DECEMBER 5, 2021

Funders are endorsing MAPS’ mission and pursuit of mass mental health backed by 35 years of innovative leadership, governance, programs, and strategies. Getting MAPS out ahead of the industry will create a commercial and cultural bar that puts patient access first.”.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. “Our Work with U.S.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

PrestoDoctor

SEPTEMBER 6, 2023

It has been a go-to option for healthcare professionals seeking to manage pain effectively for their patients. This has led many patients to explore cannabis as a potential substitute for prescription codeine. Additionally, common side effects such as drowsiness, constipation, and respiratory depression can be burdensome for patients.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

The Cannigma

JUNE 19, 2022

The country has had a medical cannabis program since 2015. Colombia’s medical cannabis program allows for research and product development, as well as prescriptions. Today, patients can access cannabis products with a prescription from a doctor. Cannabis in Colombia. CBD regulations.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

The Cannigma

DECEMBER 4, 2022

THC in 2013 but did not establish a national program. Another draft law was introduced in 2019 to expand the program; as of 2022, it was still in draft in a chamber of government. People who are caught with cannabis for personal use can avoid jail time by participating in an “ integrated assistance program.” Possible penalties.

Law 59

Law Seed-To-Sale Programs Tincture 59

Cannabis Law Report

AUGUST 7, 2021

MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics. We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. Full Job Description.

Clinical Trials 105

Clinical Trials Research and Development Compliance Compliance 105

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

The Cannigma

JUNE 1, 2021

France’s (experimental) medical cannabis program. In March, 2021, France launched a two-year experiment to gauge the effectiveness of a nationwide medical marijuana program and to prepare the ground for future distribution, according to the Health Ministry. (Shutterstock. Some 170 hospitals will participate in the two-year experiment.

Law 113

Law Epilepsy Programs Patients 113

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access.

Legislation 167

Legislation Decriminalization Access Patients 167

MMJ Recs

APRIL 1, 2024

Its non-addictive nature and minimal side effects make it an attractive alternative to conventional pharmaceuticals for many individuals seeking natural remedies. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

MMJ Recs

JANUARY 17, 2024

As the legal landscape surrounding cannabis continues to evolve, an increasing number of arthritis patients are turning to this plant for potential relief. How Medical Marijuana Can Help Arthritis Patients Medical marijuana holds significant promise in providing relief and improving the quality of life for arthritis patients.

Strains 98

Strains Marijuana Indica Microdosing 98

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

NORML

JANUARY 11, 2019

At the state level, Governor Jay Inslee of Washington launched a new program and began granting pardons to those with past criminal misdemeanor marijuana-related convictions on their record. Legislation is pending, Senate Bill 2134, to permit qualifying patients to cultivate personal use quantities of cannabis for therapeutic purposes.

Legislation 201

Legislation Decriminalization Hemp Patients 201

Veriheal

MAY 17, 2021

Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. Other states have gone beyond just medical access and have also legalized retail cannabis markets for adult consumers. ” State Doctors Oppose Legalization in Alabama.

Legalization 70

Legalization Pharmaceutical Therapy Chronic Pain 70

NORML

FEBRUARY 29, 2020

Legislation is pending, House Bill 268 and House Bill 528, to allow those convicted of simple marijuana possession to petition the court to restrict access to their records. Send a message to your lawmakers in support of access to edibles. Send a message to your governor in support of a state-legal medical cannabis program.

Legislation 148

Legislation Decriminalization Patients Edibles 148

SpeedWeed

AUGUST 27, 2021

What role does the “informal” researcher play in advancing knowledge about the drug—particularly if the investigation is not tied to any kind of formal program? Washington State legalized in 2014, which ended up splitting the legalizing industry away from patient growers. Australian Advocate. The Role of the Advocate-Cultivator.

Cultivation 67

Cultivation Research and Development Hybrid Pharmaceutical 67

Cannabis Law Report

MAY 28, 2019

Veterans Struggle to Gain Access to Medical Marijuana. Thirty-three states and the District of Columbia have enacted medical marijuana programs. Despite this expansion military veterans often face greater obstacles to gaining access to medical marijuana than other groups. Current Issues in Marijuana Regulation. May 2, 2019.

Access 49

Access Marijuana Research and Development Programs 49

Cannabis Law Report

JANUARY 23, 2022

Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. We are excited by Health Canada’s recent amendment to the special access program and look forward to supplying patients in the future.”. Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 78

Therapy Clinical Trials Decriminalization Patients 78

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. .

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104